- Home
- VANI vs CBUS Comparison
VANI vs CBUS Comparison
Compare VANI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- CBUS
- Stock Information
- Founded
- VANI 1998
- CBUS 2010
- Country
- VANI United States
- CBUS United States
- Employees
- VANI N/A
- CBUS N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CBUS Agricultural Chemicals
- Sector
- VANI Health Care
- CBUS Industrials
- Exchange
- VANI Nasdaq
- CBUS Nasdaq
- Market Cap
- VANI 81.2M
- CBUS 69.9M
- IPO Year
- VANI 2014
- CBUS 2017
- Fundamental
- Price
- VANI $1.40
- CBUS $1.30
- Analyst Decision
- VANI Strong Buy
- CBUS Strong Buy
- Analyst Count
- VANI 1
- CBUS 2
- Target Price
- VANI $4.00
- CBUS $21.25
- AVG Volume (30 Days)
- VANI 435.3K
- CBUS 180.3K
- Earning Date
- VANI 11-13-2025
- CBUS 11-13-2025
- Dividend Yield
- VANI N/A
- CBUS N/A
- EPS Growth
- VANI N/A
- CBUS N/A
- EPS
- VANI N/A
- CBUS N/A
- Revenue
- VANI N/A
- CBUS $3,794,000.00
- Revenue This Year
- VANI N/A
- CBUS $17.67
- Revenue Next Year
- VANI N/A
- CBUS $63.43
- P/E Ratio
- VANI N/A
- CBUS N/A
- Revenue Growth
- VANI N/A
- CBUS N/A
- 52 Week Low
- VANI $0.91
- CBUS $1.09
- 52 Week High
- VANI $1.92
- CBUS $4.96
- Technical
- Relative Strength Index (RSI)
- VANI 44.06
- CBUS 45.11
- Support Level
- VANI $1.36
- CBUS $1.15
- Resistance Level
- VANI $1.50
- CBUS $1.32
- Average True Range (ATR)
- VANI 0.11
- CBUS 0.10
- MACD
- VANI -0.02
- CBUS -0.02
- Stochastic Oscillator
- VANI 13.52
- CBUS 38.87
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.